CVRx, Inc. Increase (Decrease) in Accrued Liabilities
CVRx, Inc. (CVRX) reported Increase (Decrease) in Accrued Liabilities of -$2.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- CVRx, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $840.00K, a 15.83% decline year-over-year.
- CVRx, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$2.91M.
- CVRx, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $2.02M, a 251.39% increase year-over-year.
- CVRx, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $1.06M, a 50.40% decline year-over-year.
- CVRx, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $1.79M, a 30.18% decline from fiscal 2024.
- CVRx, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $2.56M.
- CVRx, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$170.00K, a 119.47% decline from fiscal 2022.
- CVRx, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $873.00K, a 60.08% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $840.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.07M 10-Q · filed 2026-08-06 | -$50.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$2.91M 10-Q · filed 2026-05-12 | -$890.00K derived: sum of 2 quarters · filed 2026-05-12 | $172.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $3.08M derived: sum of 2 quarters · filed 2026-02-13 | $4.08M derived: sum of 3 quarters · filed 2026-08-06 | $1.79M 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.06M derived: sum of 2 quarters · filed 2026-08-06 | -$229.00K 10-Q · filed 2025-11-06 | $345.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $998.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.29M 10-Q · filed 2026-08-06 | -$717.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$2.29M 10-Q · filed 2026-05-12 | -$1.72M derived: sum of 2 quarters · filed 2026-05-12 | $426.00K derived: sum of 3 quarters · filed 2026-05-12 | $354.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $574.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.71M derived: sum of 2 quarters · filed 2026-02-13 | $2.64M derived: sum of 3 quarters · filed 2026-02-13 | $2.56M 10-K · filed 2026-02-13 |
| 2024-09-30 | $2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.07M derived: sum of 2 quarters · filed 2025-11-06 | $1.99M 10-Q · filed 2025-11-06 | $1.71M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$154.00K 10-Q · filed 2025-08-05 | -$436.00K derived: sum of 3 quarters · filed 2025-08-05 | -$68.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$82.00K 10-Q · filed 2025-05-09 | -$364.00K derived: sum of 2 quarters · filed 2025-05-09 | $4.00K derived: sum of 3 quarters · filed 2025-05-09 | $146.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $86.00K derived: sum of 2 quarters · filed 2025-02-18 | $228.00K derived: sum of 3 quarters · filed 2025-02-18 | -$170.00K 10-K · filed 2025-02-18 |
| 2023-09-30 | $368.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $510.00K derived: sum of 2 quarters · filed 2024-11-01 | $112.00K 10-Q · filed 2024-11-01 | $401.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$256.00K 10-Q · filed 2024-08-02 | $33.00K derived: sum of 3 quarters · filed 2024-08-02 | $869.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$398.00K 10-Q · filed 2024-05-10 | -$109.00K derived: sum of 2 quarters · filed 2024-05-10 | $727.00K derived: sum of 3 quarters · filed 2024-05-10 | $1.07M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $1.13M derived: sum of 2 quarters · filed 2024-02-09 | $1.47M derived: sum of 3 quarters · filed 2024-02-09 | $873.00K 10-K · filed 2024-02-09 |
| 2022-09-30 | $836.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $1.18M derived: sum of 2 quarters · filed 2023-10-31 | $584.00K 10-Q · filed 2023-10-31 | $1.21M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $344.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$252.00K 10-Q · filed 2023-08-03 | $377.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.64M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$596.00K 10-Q · filed 2023-05-11 | $33.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.29M derived: sum of 3 quarters · filed 2023-05-11 | $1.65M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $629.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.89M derived: sum of 2 quarters · filed 2023-02-10 | $2.24M derived: sum of 3 quarters · filed 2023-02-10 | $2.19M 10-K · filed 2023-02-10 |
| 2021-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.61M derived: sum of 2 quarters · filed 2022-11-04 | $1.56M 10-Q · filed 2022-11-04 | $884.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $353.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $298.00K 10-Q · filed 2022-08-01 | -$376.00K derived: sum of 3 quarters · filed 2022-08-01 | -$1.91M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | -$55.00K 10-Q · filed 2022-05-02 | -$729.00K derived: sum of 2 quarters · filed 2022-05-02 | -$2.27M derived: sum of 3 quarters · filed 2022-05-02 | |
| 2020-12-31 | -$674.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$2.21M derived: sum of 2 quarters · filed 2022-02-22 | -$838.00K 10-K · filed 2022-02-22 | |
| 2020-09-30 | -$1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$164.00K 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $1.37M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |